创伤性脑损伤中的皮层扩散性抑制
本文综述皮层扩散性抑制(CSD)在创伤性脑损伤(TBI)中的病理生理作用。CSD是皮层灰质内扩散的去极化波,可破坏神经元和胶质细胞离子平衡,增加能量需求并引发代谢危机,导致继发性损伤和神经元死亡。随着颅内脑电图/皮层脑电图的应用,CSD已被识别为TBI不良结局的重要机制,且在各类TBI中频繁发生,为靶向治疗提供潜在方向。
要点
- CSD是TBI后频繁发生的病理生理事件,可导致继发性脑损伤。
- 颅内脑电图/皮层脑电图是识别CSD的关键监测手段。
- CSD作为药理学靶点,有望为TBI患者提供靶向治疗策略。
核心结论
- CSD是TBI后频繁发生的病理生理现象,可引发代谢危机并导致继发性损伤和神经元死亡。
- 随着颅内脑电图/皮层脑电图的应用,CSD已被识别为TBI不良结局的重要机制。
- 以CSD为药理学靶点的治疗策略在TBI患者中具有潜在临床价值。
研究设计与样本
- 本文为综述,回顾了数十年来关于CSD与TBI相互作用的研究工作。
- 文中讨论了神经免疫细胞在TBI背景下对CSD的作用。
- 文中探讨了以CSD为药理学靶点的当前治疗策略及其在TBI患者中的临床使用。
主要发现
- CSD表现为皮层灰质内扩散的去极化波,破坏神经元和胶质细胞离子平衡。
- CSD增加能量需求,可导致代谢危机,进而造成继发性损伤和神经元死亡。
- CSD在脑震荡、硬膜外和硬膜下血肿、弥漫性轴索损伤及蛛网膜下腔出血等各类TBI中频繁发生。
临床怎么用
- 在TBI患者中应关注CSD的发生,颅内脑电图/皮层脑电图有助于识别CSD。
- CSD可作为TBI靶向治疗的潜在药理学靶点。
局限性
- 对CSD与TBI之间相互作用的完整理解尚未实现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cortical spreading depression (CSD) is a pathophysiologic phenomenon that describes an expanding wave of depolarization within the cortical gray matter. Originally described over 70 years ago, this spreading depression disrupts neuronal and glial ionic equilibrium, leading to increased energy demands that can cause a metabolic crisis. This results in secondary insult, further perpetuating brain injury and neuronal death. Initially not thought to be of clinical significance, the view of CSD was modified with the advent of intracranial electroencephalography, or electrocorticography. With these improved monitoring techniques, CSD has been identified as a major mechanism by which traumatic brain injury (TBI) imparts its negative sequalae. TBI is a heterogenous disease process that runs the gamut of clinical presentations. This includes concussion, epidural and subdural hematoma, diffuse axonal injury, and subarachnoid hemorrhage. Nonetheless, CSD appears to be frequently occurring among the various types of TBI, thus allowing for the potential development of targeted therapies in an otherwise ill-fated patient cohort. Although a complete understanding of the interplay between CSD and TBI has not yet been achieved, the authors recount the efforts that have been employed over the last several decades in an effort to bridge this gap. In addition, our current understanding of the role neuroimmune cells play in CSD is discussed in the context of TBI. Finally, current therapeutic strategies using CSD as a pharmacologic target are explored with respect to their clinical use in patients with TBI.
引用
- Soldozy S, Sharifi KA, Desai B, et al. Cortical Spreading Depression in the Setting of Traumatic Brain Injury. World Neurosurg. 2019. PMID: 31655239. doi:10.1016/j.wneu.2019.10.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。